Edmund C. Lattime of Plainsboro, known for his work in tumor immunology, has been named the new deputy director at the Cancer Institute of New Jersey (CINJ).##M:[more]## He joined CINJ in 1998 following faculty appointments first at Memorial Sloan Kettering and then at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia. His laboratory and clinical studies focus on tumor immunology, gene therapy, and the development of vaccines for cancer treatment. As deputy director, he will be responsible for continuing the development of the research programs at CINJ.
After receiving his doctorate degree at Rutgers University, Lattime did a postdoctoral fellowship at the Memorial Sloan-Kettering Cancer Center where he carried out the defining studies into the identification and regulation of natural cytotoxic cells. Recruited to the department of medicine, division of neoplastic diseases at Thomas Jefferson University, Philadelphia, in 1989, Lattime translated his preclinical studies in both human melanoma and bladder cancer. While at Jefferson, Lattime was a professor of medicine and co-leader of the genitourinary cancer program at the Kimmel Cancer Center.
Lattime is also professor of surgery, director of surgical oncology research, and professor of molecular genetics, microbiology, and immunology at UMDNJ-Robert Wood Johnson Medical School.
His wife, Holly Lattime, is a medical writer. His daughter, Sarah, is a sixth grade student at Grover Middle School.
